Background
Dental caries represents one of the most prevalent human diseases worldwide and is becoming a worrying public health problem [
1‐
3]. It is a chronic disease characterized by localized demineralization of dental structures, caused by microbial metabolic products, specifically organic acids coming from dental plaque (oral biofilm). The establishment of a cariogenic biofilm occurs due to an imbalance of complex interactions between oral microorganisms, host and dietary factors [
4,
5]. Biofilms are defined as highly dynamic microbial communities immersed in an extracellular matrix (ECM). The ECM provides a three-dimensional (3D) structure and increases acidic niches that restrict the access of buffering saliva [
6‐
8]. Preventing such biofilm formation is paramount to prevent dental caries occurrence.
In case of extremely destructive caries lesion with rapid progression (i.e., severe early childhood caries or S-ECC), the microorganisms
Streptococcus mutans and
Candida albicans are detected, concomitantly with a high intake of dietary sugars [
9,
10]. When sucrose is present the adhesion between these two organisms is enhanced [
11,
12]. Moreover, the symbiotic interactions between
S. mutans and
C. albicans increased acid production and extracellular glucan formation, enabling the assembly of a dense and abundant matrix rich in exopolysaccharides (EPS) [
11,
13]. The EPS will behave as a bridge between fungal and bacterial cells [
12].
S. mutans is widely recognized as an etiological factor of dental caries. This species is acidogenic and aciduric [
14,
15], and encodes exoenzymes glucosyltransferases (Gtfs) that synthesize EPS (when sucrose is available) [
16].
S. mutans is the main producer of ECM in dental biofilms [
16]. The Gtfs are also components of saliva-pellicle and foment adhesion and accumulation of
S. mutans and other microorganisms [
17], including
C. albicans that provides an abundance of binding sites for Gtfs derived from
S. mutans [
11].
C. albicans is the most commonly detected fungal organism on human mucosal surfaces and co-adheres with other commensal species, helping in biofilm formation [
18,
19], when properly sugar resources are available in the diet [
20]. This fungus has an extraordinary acid production and tolerance capability, besides aspartyl protease secretion [
21,
22]. These exoenzymes are capable of degrading dentinal collagen under acidic conditions, increasing the cariogenic potential of biofilms [
21,
22].
Commonly therapies have a microorganism as a target (as an individual causative agent); however, treatments for infectious diseases should consider a polymicrobial cause, where the interactions between microorganism can increase pathogenicity [
23], and the 3D structure of ECM that protects microorganisms from antimicrobial agents [
7]. The biofilm ECM-rich in insoluble EPS restricts the rinsing and buffering effect of saliva on surfaces while conferring protection to microorganisms from therapeutic agents by limiting their diffusion [
8]. Thus, the absence of this type of ECM effect would minimize the capacity of acids to demineralize dental surfaces in the presence of saliva, being an attractive way to control the formation and accumulation of pathogenic biofilms and tooth decay [
24].
Current approaches to control virulent biofilms in the mouth are very limited. Chlorhexidine is a broad-spectrum bactericidal agent that suppresses mutans streptococci levels in saliva but is less effective against biofilms (as revised by Mattos-Graner et al., [
15]). Fluoride is the mainstay of caries prevention; however, it offers incomplete protection against caries and does not address the infectious aspects of the disease efficiently [
25]. Fluoride is mainly involved in the remineralization process and slightly affects bacterial metabolism, reducing acid production [
26]. Therefore, new anti-biofilm agents have been extensively searched.
When
S. mutans was used as a single pathogen in vitro anti-plaque and in vivo anti-caries studies to test the effect of propolis (a natural, non-toxic beehive product), some compounds were identified as effective. Among them are worth highlighting a bioflavonoid (myricetin) and a terpenoid (
tt-farnesol) [
27‐
29]. Myricetin is an effective inhibitor of Gtfs enzymes in solution and reduces the expression of the
gtfBC genes [
30,
31], meanwhile
tt-farnesol targets the cytoplasmatic membrane, decreasing acid tolerance of
S. mutans [
24,
28,
32]. Therefore, the combination of alternative agents and fluoride to improve the action that each one presented separately is an interesting strategy for anti-biofilm therapies [
28,
31], even more when used against a more pathogenic setting (i.e.,
S. mutans and
C. albicans dual-species biofilm [
12]). Thus, this study evaluated the effect of
tt-farnesol and myricetin on
S. mutans and
C. albicans dual-species biofilm, especially on exopolysaccharides found in the ECM.
Discussion
Due to the widespread of caries, costs and inconvenience that this disease generates [
1,
2] exist a continuous interest in developing novel strategies to control cariogenic biofilms that act against its virulence traits. Trying to reproduce the complexity of oral biofilm is difficult because of the interference of many factors (e.g., complex microbiota, salivary flow, diet, others). The
S. mutans and
C. albicans dual-species biofilm model used here was to represent a critical clinical situation, since these two species are commonly found in the oral cavity and are proven pathogens when the host and environmental conditions enable them [
14,
20‐
22]. Specifically, these two microorganisms were used to grow a biofilm characterized by its glucan-rich matrix [
12]), typically found in cases of destructive caries, especially in S-ECC (as revised by Hajishengallis et al. [
36]).
The use of chlorhexidine (a broad-spectrum antimicrobial agent) is considered the gold-standard therapy to control oral biofilms. However, chlorhexidine suppresses the oral microbiota [
15] and has a restricted use (only for a period of 14 days), because of its collateral effects [
37]. In addition, fluoride is the gold-standard for caries prevention, but it offers incomplete protection against the disease and inadequately treats the infectious aspect of caries [
25]. Consequently, natural agents that could increase the effectiveness of topically applied fluoride have been investigated to improve oral care [
24].
Here, trying to simulate human exposure to oral care products, treatments were applied twice daily during a brief time (1.5 min). It was observed a similar diminution of water-soluble EPS in the ECM when a combination therapy (MF250) and a positive control (0.12% CHX) were used. Therefore, MF250 affected negatively biofilm development, making these biofilms potentially less pathogenic. This effect in reducing exopolysaccharides is significant because the ability of microorganisms to synthesize glucan may be more important for virulence than its population itself [
38], as a debilitated ECM may not provide an adequate 3D structure and stability for microorganisms in the biofilm. Moreover, saliva could perform its buffer activity, possibly decreasing the formation of acidic niches within dental biofilms.
However, even showing impact in the EMC composition, it was observed a pH drop in the culture media (except for CHX), reaching critical values that can trigger a demineralization process (5.5 for enamel and 6.5 for dentin) [
39]. Nevertheless, there was a lower drop in pH when fluoride was present in the topical treatments, because it reduces the production of acids by microorganisms in biofilms and releases ions to assist in the remineralization process, which are the major pathways to prevent early caries lesions [
26].
Although ECM in biofilms protects microorganisms and EPS negatively charged affects penetration (and antimicrobial activity) of CHX [
8,
40], the inhibitory power of the positive control CHX was evident regardless of the treatment regimen employed. This effect could be explained because the CHX was designed to modify the integrity of cell membranes, causing dispersion of microbial components of low molecular weight, particularly in the surfaces of Gram-positive bacteria [
41]. Moreover, when microbial cells are dead, there are fewer surfaces available for Gtfs adhesion and EPS synthesis. However, in cases of caries with rapid progression (i.e., S-ECC), chlorhexidine antifungal effectiveness must be confirmed on in vivo and in clinical studies, because there may be a different behavior in biofilms formed on teeth of live hosts where several factors may be interacting.
C. albicans has several virulence factors, including its capacity to switch its morphology that is influenced by quorum-sensing molecules (i.e.
, tyrosol from yeast to hypha, and farnesol from hypha to yeast), biofilm formation, and control of nutrient competition [
42‐
44]. Therefore, the use of
tt-farnesol by itself may explain the higher numbers of
C. albicans, compared to all other treatments in the regimen to disrupt pre-formed biofilms (regimen one), because farnesol stimulates yeast morphology. However, this data was opposite to a previous study that observed lower
C. albicans population in single-species biofilms in the presence of farnesol [
43]. Therefore,
C. albicans in a dual-species biofilm with
S. mutans may behave differently when challenged by therapeutic agents, which may benefit both species to maintain a symbiotic relationship, and this behavior may be dependent upon the treatment regimen employed.
Furthermore, when tt-farnesol was mixed with myricetin (MF) and with fluoride (MF250), the population of both species was higher than the ones after treatments with the other agents in the regimen that treated salivary pellicle, before microbial inoculation (regimen two), which was unexpected. Our theory was that topically treating the pellicle would prevent biofilm accumulation and microbial population increase (compared to the negative control vehicle). The reason for the distinct population outcome from both regimens is unclear because the quantity of ECM components was lower for treatments with combination therapy. Nevertheless, we hypothesize that the presence of residual treatment on the pellicle (in regimen two) could have elicited a stress response from the microorganisms to build up biofilm, leading to the higher biomass and ASP observed for this regimen, compared to the regimen one (treatment starting after 19 h of biofilm development). Additional studies are warranted to clarify this theory further.
In addition, change in drug concentration or increase in exposure time may improve the results in reducing the number of viable cells and EPS in the matrix. The treatment potential of MF250 was confirmed by reduction of matrix extracellular formation (WSP), similarly to the positive control (CHX) in regimen one. Therefore, additional research should be performed with molecules from natural sources, such as the ones used here, so that more positive results are collected, showing their pharmacological potential in the protection of oral health.